Glucagon-like peptide-1 (GLP-1) is an incretin hormone produced by the enteroendocrine L-cell that potently stimulates insulin secretion. Although signaling pathways promoting GLP-1 secretion are well characterized, the mechanism by which GLP-1 containing granules fuse to the L-cell membrane remain elusive. RT-PCR and protein analysis indicate that vesicle-associated membrane protein 2 (VAMP2) is expressed and localized to secretory granules in the murine GLUTag L-cell model. VAMP2, but not VAMP1, interacted with the core SNARE complex protein, Syntaxin 1a, in GLUTag cells. Tetanus toxin (TetX) cleavage of VAMP2 in GLUTag cells prevented glucose-dependent insulinotropic peptide (GIP)- and oleic acid (OA)-stimulated GLP-1 secretion, as well ...
Vesicle-associated membrane protein-2 (VAMP-2) and cellubrevin are associated with the membrane of i...
The glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) is a key target for type 2 diabetes (T2D) trea...
The glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) is a key target for type 2 diabetes (T2D) trea...
Glucagon-like peptide-1 (GLP-1) is an intestinal L-cell hormone that potentiates glucose- dependent ...
Glucagon-like peptide-1 (GLP-1) is an intestinal L-cell hormone that potentiates glucose- dependent ...
Glucagon-like Peptide-1 (GLP-1) is an incretin secreted from intestinal L-cells. Although pathways p...
Glucagon-like Peptide-1 (GLP-1) is an incretin secreted from intestinal L-cells. Although pathways p...
The incretin glucagon-like peptide-1 (GLP-1) is a rhythmically secreted insulin-secretion enhancing ...
Exocytosis of the hormone, glucagon-like peptide-1 (GLP-1), by the intestinal L-cell is essential fo...
SummaryOptimal insulin secretion required to maintain glucose homeostasis is the summation of total ...
GLP-1 (glucagon-like peptide-1) is a potent insulin secretagogue released from L cells in the intest...
Glucagon-like peptide-1 (GLP-1) is released from intesti-nal L-cells in response to a range of nutri...
GLP-1 (glucagon-like peptide-1) is a potent insulin secretagogue released from L cells in the intest...
Glucagon-like peptide-1 (GLP-1), produced by intestinal L cells, is an important incretin with insul...
The glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) is a key target for type 2 diabetes (T2D) trea...
Vesicle-associated membrane protein-2 (VAMP-2) and cellubrevin are associated with the membrane of i...
The glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) is a key target for type 2 diabetes (T2D) trea...
The glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) is a key target for type 2 diabetes (T2D) trea...
Glucagon-like peptide-1 (GLP-1) is an intestinal L-cell hormone that potentiates glucose- dependent ...
Glucagon-like peptide-1 (GLP-1) is an intestinal L-cell hormone that potentiates glucose- dependent ...
Glucagon-like Peptide-1 (GLP-1) is an incretin secreted from intestinal L-cells. Although pathways p...
Glucagon-like Peptide-1 (GLP-1) is an incretin secreted from intestinal L-cells. Although pathways p...
The incretin glucagon-like peptide-1 (GLP-1) is a rhythmically secreted insulin-secretion enhancing ...
Exocytosis of the hormone, glucagon-like peptide-1 (GLP-1), by the intestinal L-cell is essential fo...
SummaryOptimal insulin secretion required to maintain glucose homeostasis is the summation of total ...
GLP-1 (glucagon-like peptide-1) is a potent insulin secretagogue released from L cells in the intest...
Glucagon-like peptide-1 (GLP-1) is released from intesti-nal L-cells in response to a range of nutri...
GLP-1 (glucagon-like peptide-1) is a potent insulin secretagogue released from L cells in the intest...
Glucagon-like peptide-1 (GLP-1), produced by intestinal L cells, is an important incretin with insul...
The glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) is a key target for type 2 diabetes (T2D) trea...
Vesicle-associated membrane protein-2 (VAMP-2) and cellubrevin are associated with the membrane of i...
The glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) is a key target for type 2 diabetes (T2D) trea...
The glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) is a key target for type 2 diabetes (T2D) trea...